No, an 83-year-old female smoker does not require annual LDCT screening for lung cancer.
Lung cancer screening with LDCT should be discontinued in this patient because she exceeds the recommended upper age limit of 80 years established by current guidelines.
Age-Based Screening Recommendations
The most recent and authoritative guidelines establish clear age cutoffs for lung cancer screening:
- USPSTF 2021 guidelines recommend annual LDCT screening for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years 1
- The 2014 USPSTF guidelines recommended screening for ages 55 to 74 years 2
- Screening should be discontinued once a person reaches age 80, has not smoked for 15 years, or develops health problems that substantially limit life expectancy or ability/willingness to undergo curative lung surgery 1
NCCN Guidelines: The Exception That Proves Individualization
While the 2025 NCCN guidelines removed any upper age cutoff 3, this recommendation is explicitly based on individual candidacy for curative-intent treatment rather than chronological age alone. The NCCN emphasizes that eligibility should be determined by:
- Functional status
- Comorbidities that could impede curative treatment
- Patient values and willingness to undergo treatment
- Whether the patient remains a candidate for definitive treatment
The NCCN acknowledges that some individuals in their 60s may not be eligible for treatment and should not undergo screening, while some octogenarians at high risk who are fit for treatment may deserve access to early diagnosis 3.
Clinical Decision-Making for This Patient
For your 83-year-old patient, the critical question is not whether she meets age criteria for routine screening, but rather:
- Is she a candidate for curative-intent treatment (surgery, stereotactic radiation, or definitive chemoradiation)?
- What is her functional status and comorbidity burden?
- What is her life expectancy independent of lung cancer risk?
- What are her values and preferences regarding aggressive workup and treatment?
If she is NOT a candidate for curative treatment due to:
- Poor functional status
- Significant comorbidities (severe COPD, heart failure, etc.)
- Limited life expectancy from other conditions
- Patient preference against aggressive intervention
Then screening should NOT be performed, as it would only lead to overdiagnosis, unnecessary anxiety, and potential harms from invasive procedures without mortality benefit.
If she IS an exceptionally fit octogenarian who:
- Has excellent functional status
- Has minimal comorbidities
- Would be a surgical or definitive treatment candidate
- Desires aggressive management
Then screening could be considered on an individualized basis following the NCCN framework 3, though this represents a minority of 83-year-olds and falls outside standard USPSTF population-based recommendations.
Evidence on Harms in Older Adults
The evidence supporting screening comes primarily from trials with upper age limits of 74-80 years 2, 1, 4. Important harms to consider at age 83 include:
- False-positive results leading to invasive procedures (17 per 1000 screened in NLST) 4
- Overdiagnosis estimated at 18% (95% CI 0-36%) 5
- Incidental findings occurring in 4.4-40.7% of screened individuals 4
- Increased risk of complications from diagnostic procedures in older adults with comorbidities
Common Pitfalls to Avoid
- Do not screen based solely on smoking history without considering treatment candidacy and life expectancy
- Do not continue screening indefinitely in patients who would not pursue treatment if cancer were found
- Do not assume all smokers benefit equally—the balance of benefits and harms shifts unfavorably with advanced age and comorbidities
For the vast majority of 83-year-old patients, annual LDCT screening is not recommended and should be discontinued 1.